A large TAT deletion in a tyrosinaemia type II patient.
Legarda M, Wlodarczyk K, Lage S, Andrade F, Kim GJ, Bausch E, Scherer G, Aldamiz-Echevarria LJ.
Legarda M, et al.
Mol Genet Metab. 2011 Nov;104(3):407-9. doi: 10.1016/j.ymgme.2011.05.009. Epub 2011 May 16.
Mol Genet Metab. 2011.
PMID: 21636300